こちら - 3D MATRIX [medical technology]
Contents
1. TDM 64 1 TDM 64 12. DDS Drug Delivery System
3. Scaffold GLP Good Laboratory Practce i pH
4. KOL Key Opinion Leader TOP 2012 4 2012 6 13 2012 4 1 107 1 TDM 621 2 TDM 64 1 3
5. a TDM 711 TDM 711 TDM 711 3
6. 2012 4 2013 4 TDM 621 1009 60
7. T pH bFGF 1 http www sharedresearch jp 24 26 s Shared 9esearch 2012 12728 7777 PDGF PuraMatrix R A D
8. TDM 621 2012 4 TDM 621 1 000 MR 100 TDM 621
9. MTT MIT 2014 am
10. TOP 1 1 http www sharedresearch jp 14 26 hared Wesearch 2012 12 28 7777 CE 7 7 000 el 1 bb 058 5914 5 931 SS O00 811 18 1 174 2 7 71 0171 3170 7 169 3 168 6 i150 140 100 a 7 0 gg 10 11 18 13 1 5 000 4 OO 3 000 1 000 0S 0 20 9 ji Fo Lm m
11. mm CPC Scientfic Inc 3 3 TDM 621 2011 5 2009 4 1 8001
12. 2012 4 9 TDM 621 TDM 621 TOP MLPFS CUSTODY ACCOUNT Excelsior Medical Co Ltd 24 69 9 19 2012 10 4 19 http7Xwww sharedresearchJp 22 26 s Shared Wesearch 2012 12728
13. m m 2013 4 m 2013 4 2014 4 m 2013 4 2015 4 1 http www sharedresearch jp 4 26 Shared Wesearch 2012 12728 7777 m 2013 4 CE EU EU CE 2014 4 2015 4
14. MIT sehn RI 2014F11A20E SHE RE MT 2003 4 15 2017 7 21 Purahdatrix WO 067014570 _ SM 2023 3 16 PuraMatrix SE 2008 11 30 2021 2 5 EP 717398 2g00 15 1 2022 2 5 Purakdatrix LS 7713929 2gn1 5 11
15. m 2012 9 5 MIT m 507629 MIT 3
16. GLP TDM 711 i 2010 9 FDA IDE 2011 7 IDE 2012 2 Forsyth Institute 2012 6 FDA C DDS DDS DDS bFGF PDGF
17. 3 III 1 1 2 II 3 1 Nd 1 http7 www sharedresearchjp
18. 2007 10 579 1 448 3DM Investmen LLC Massachusetts Insttute of Technology 2009 11 500 1 250 4 JAIC TAIB JAIC Asian Balanced Private Equity Fund m 2010 9 200 400 m 2010 9 300 600 Excelsior Medical Co Ltd Daewoong Pharmaceutical Co LTD 2011 10 1 352 700 1 http7Xwww sharedresearch p 19 26 Sharedd Wesearch 2012 12728
19. 2011 7 2012 2 3 D Matrix Europe SAS 2012 3 2012 4 3 D Matrix Inc 2007 10 3 D Matix Inc 2009 4 TOP amp 2012 9 2012 9 6 Massachusetts Institute of Technology MIT
20. D D Asp COOH NH2 A A Ala R R Arg http7 www sharedresearchjp 23 26 Shared 05Wesearch 2012 12728 7777 ADME ADME Absorption Distibuton
21. TOP Massachusetts Insttute of Technology MIT Shuguang Zhang 2004 5 1992 MIT Shuguang Zhang MIT MIT 2001 5 3 D Matix Inc 2004 5
22. MIT MIT MIT 2001 5 3 D Matrix Inc m 3 D Matrix Tnc 100 m 3 D Matrix Europe SAS 1009 6
23. 10 TDM 621 2012 4 1 4521 TDM 621 1 000 MR 100 TDM 621
24. MIT MIT 3 D Matrix Inc 2003 4 MIT Exclusive Patent License Agreement MIT 2004 10 3 D Matrix Inc License and Supply Agreement 3 D http7Xwww sharedresearchJp 11 26 s Shared Wesearch 2012 12728 7777 Matrix Inc 2007 10 3 D Matix Inc 3 D Matix Inc
25. 753 354 3 14 26 48 310 309 2012 4 300 http7 www sharedresearchjp 16 26 Shared 05Wesearch 2012 12728 7777 m TDM 621 2011 5 PMDA
26. TDM 631 TDM 631 TDM 631 TDM 631 X B
27. TDM 621 Daewoong Pharmaceutcal Co LTD Excelsior Medical Co Ltd TDM 641 m 2 2012 4 100 MTA
28. RNA 2013 4 2012 7 17 2012 8 31 1 2 4 604 9 208 2012 6 2012 6 18 TDM 711 TDM 711 Forsyth Insttute 2012 2
29. DDS MIT MIT f PuraMatrix PuraMatrix Ee i i a i FP EE A 5 ONH 3 R D 1 2 3
30. MBA 1999 ASDAQ7774 2002 2370 COO 2003 10 2005 2007 1998 1 2005 2007 2012 7 IN
31. MIT m m SR Weaknesses
32. m 5057781 m MIT 3 http7Xwww sharedresearchJp 21 26 Shared Wesearch 2012 12 28 7777
33. 6 2016 1 344 iDATA Research 30 509 2016 1 344M cm ipata 1 600 F M 1 400 1 200 1 0OO 800 1 400 gh CYOG CTYU7 CTOUB Cr CTTOUE CTY11E CT1EE CT13E CT19E CYISE CTY16E SEALANTS HEMOSTATS 80 109 113 685 11 526
34. gt UMHBE 1 TDM Bg1 C http7Xwww sharedresearch p 7 26 hared Wesearch 2012 12 28 7777 1987 C 1 2008 1 30 2008 12 14 5 1
35. http goo gl Pp6QH http7Xwww sharedresearchJp 17 26 2012 12728 7777 m Compositions and methods for cardiac tssue protecton and regeneraton EP2089047 m 3 D Matrix Inc
36. 2 P 3 4
37. m TDM 621 PMDA CE EU EU CE FDA m TDM 711 2012 2 15 7 FDA m TDM 64 1 2013 4
38. 170 TDM 621 50 300
39. http7Xwww sharedresearchJp 5 26 hared Wesearch 2012 12728 7777 1992 MIT Shuguang Zhang R A D 3 RADA 16 pH ADMEi 30
40. MR 700 2012 6 2011 10 1 902 152 5 533 971 398 589 66 3
41. Shared Research SR Inc SR Inc SR Inc http7 www sharedresearchjp 26 26 Shared 05Wesearch
42. 2012 2013 4 2015 4 2012 4 CE EU EU CE 2013 4 CE i 2015 4 2012 4 TDM 621 2011 5 1 4538
43. 2009 8 PMDA 2010 1 2010 8 13B1X10105 3 D Matrix Inc IDE FDA Daewoong Pharmaceutical Co LTD PARTNERSHIP AGREEMENT 2010 9 Excelsior Medical Co Ltd LICENSE AGREEMENT 2009 4 m NM mn OO m 2011 5 PMDA PMDA 3 D Matrix Inc FDA IDE
44. CSL amp 1 4502 2009 Medmarket Diligence 1 4503 lt 1 3401 gt CSL 1 4559
45. 2012 10 15 http goo g bKoGP mm 3 D Matix Asia Pte Ltd 2012 10 100 3 amp 12 4 13 4 13 4 CW 2 491 194 9 4Q 47 45 120 9 1 11 9 15Q 1Q4 112 132 134 185 0 21
46. A6K siRNA DDS siRNA PuraMatrix Becton Dickinson and Company
47. m TDM 64 1 i 2012 2 20 m 2011 Phase I 2012 4 2 2011 12 9 2012 4 2 2 400 TDM 621
48. 15 FDA 2012 4 2012 4 12 2012 4 1 100 550 300 456 256 477 255 478 TDM 621 TDM 621 1 4538 1 4521
49. sr_inquiries sharedresearch jp 13 4 2 491 124 9W 5 bh pt Ts Te1 dd a LE 7 14 18 7 Q8 1Q 4 11 3 12 10 10 402 158 1 107 805 2 5 5D 5d 5 45r 1 75 7 9 17 5 65 4 2 354 15 3D4 39 0 5 50 510 310 28 86 1 534 309 27 9 5 5 5 7 j5Ba 178 EFS 9 52 5 9 7 4 Else EPS 4 5 hPS Qn Qn nn Aan BPS 171 1219 172 0 15Q 2 12 5 1 5 1 758 594 G66 2 501 7 58 19 2 30
50. 2009 11 30 2010 1 2007 12 160 2008 1 2009 3 TDM 621 TDM 621
51. 2004 5 3 D Matrix Inc LICENSE AND SUPPLY AGREEMENT 3 D Matrix Inc PuraMatrix 2007 10 3 D Matrix Inc Becton Dickinson and Company SUPPLY AGREEMENT PuraMatrix RADA16 2004 10 2008 3 2D08 10 2009 7
52. M TDM 711 http7Xwww sharedresearchJp 10 26 Sharedd Wesearch 2012 12728 7777 TDM 711 TDM 711
53. 445 200 2012 4 4 588 800 10 2012 9 TOP Qg 4 og 19 4 11 12 4 22 434 131 2 13 18 100 FGF 1 2 40 5 1 7 4 1 400 5 79 9 11 10 90 C 1 20 FCF NFA B C 457 1 SR
54. 2 3 2012 7 2012 7 31 2012 360 RNA
55. DDS MTA
56. 3 1 21 1 i 51 34 309 LE i 97 9 91 9 MSR 1 http www sharedresearch jp 18 26 Shared Wesearch 2012 12728 7777 QB 4 ng 4 1 11 5 1 758 393 39 25 17 39 718 594 41 2 501 5 BB 19 2 30 5 7 7 397 9 qo 5 5 4 604 5 5 9 733 1 19H 1 199 3 055 12 15 29 d Pl an ta 0 0 0 15 9 5 31 49 112 0 0 0 5 0
57. AH TOP t SR
58. T MR 700 Daewoong Pharmaceutical Co LTD Excelsior Medical Co Ltd Daewoong Pharmaceutcal Co LTD Excelsior Medical Co Ltd 14 000 1cc SR b TDM 641 TDM 641 TDM 641
59. TDM 641 2013 4 2014 4 2015 4 TDM 631 2014 4 2015 4 TDM 711 2012 2 2014 4 2015 4 mgm m 2015 4
60. m PMDA m m ISO13485 FDA m CE m FDA m 2013 4 1 2012 9 13 2013 4 1 0 232 232 123 2012 4 25 TDM
61. 210 204 204 TDM 621 2011 4 i 1 PMDA TDM 621 TDM 621 m TDM 711 2011 7 FDA IDE 2011 4 158 2010 4 402 A
62. 182 269 533 34 1 4971 27 79 am TDM 621 PMDA TDM 621 1 4538 1 4521 2012 4 9 2012 9 25 f TDM 621 CE EU EU
63. 1 Informed Consent 2 3 TDM 621
64. 1 http www sharedresearch jp 13 26 hared Wesearch 2012 12728 7777 lt lt gt gt 6 ss ESSSS 4 1 0 AA 2 A 10 SW Strengths Weaknesses Strengths m
65. SR 2015 4 2011 10 2012 6 Re i 1 Pe TOP Massachusetts Institute of Technology MIT 1 4 1 MIT MIT
66. 4 DDS
67. 2004 10 3 DMatix Inc LICENSE AND SUPPLY AGREEMENT 3 D Matrix Inc MIT MIT Scientific Founders 2007 10 3 D Matrix Inc a http www sharedresearch jp 20 26 Shared 059esearch 2012 12728 7777 1992 MIT Shuguanqg Zhang 2001 5 MIT 3 D Matrix Inc 3 D Matrix Inc MIT Exclusive Patent License Agreement 2003 4
68. 149 150 m TDM 621 2011 5 PMDA TDM 621 1 4538 TDM 621 mm TDM 711 2011 7 FDA IDE 5 2012 2
69. 7777 SR 2012 12 28 3076 12 18 12 6324 12 20 12 8423 12 28 12 12 20 12 6754 12 20 12 1S 4283 12 20 12 9882 11 01 12 2767 12 20 12 4847 11 13 12 6890 12 20 12 2492 12 27 12 24 12 12 20 12 6750 12 20 12 9904 12 20 12 4849 12 20 12 9441 12 20 12 HD 8016a 12 12 12 3730 12 20 12 8016 12 18 12 754 1 12 20 12
70. 1 2 3 f TDM 621 2009 2013 4 3 4 RADA16
71. http7 www sharedresearchjp 12 26 Shared 059esearch 2012 12728 7777 MIT gt gD me _ 1 2 3 3
72. TDM 621 http www sharedresearch jp 8 26 Shared eesearch 2012 12728 7777 momed Cnet 5 2 TDM 621 TDM 621 2010 1 K 97 i 2
73. 2012 2013 4 http7 www sharedresearchjp 3 26 Shared 05Wesearch 2012 12728 7777 13 12 4 Fn 194 5 7 154 251 5 q1 9 9 1 4 2 2 PIE 971 ah RWati 1 IE 5 795 354 5HB 14 1 9H 9 5 9 301 310 5H3 BB ia 9 425 25W 234W 9 300 309 USR ff 2 491 124 9 TDM 621 PMDA
74. 4583 12 26 12 2370 12 27 12 8060 12 20 12 3664 12 20 12 4763 12 20 12 4680 12 20 12 8999 11 29 12 4681 12 20 12 4321 12 27 12 6920 12 20 12 6249 12 20 12 9419 12 20 12 6287 12 20 12 2769 12 27 12 8136 12 20 12 7455 12 20 12 3360 12 28 12 2593 12 20 12 3046 12 20 12 9384 12 20 12
75. TDM 621 1 4538 2012 4 1 4521 m TDM 711 2011 7 FDA IDE 2012 2 Forsyth Insttute m TDM 641 2012 2 20 mp
76. TDM 621 97 2012 4 m 2 gt a _2012 gt 201 2 2 2012 4 TN nl _ 15 _ TDM 641
77. 16 RADA16 2 TOP TOP 1 http7 www sharedresearchjp 25 26 Shared 05Wesearch 2012 12728
78. TDM 631 B B_Matrt Thes ghmrkmlmmi im ccd red was pe ed mr DFEHr ey Tor He gem tf TRI RMTeETGa Wt i Fest har Emr held mt ry a rd Fart when FD Mtr mor eT CT A a TDM 621 RADA16 TDM 621 TDM 621 TDM 621 TDM 621 pH
79. 2453 12 27 12 2362 12 20 12 7777 12 28 12 6063 12 20 12 9982 12 26 12 2353 12 20 12 9793 12 20 12 6157 12 20 12 4819 12 21 12 8233 12 27 12 7532 12 20 12 1 st 3644 12 20 12 4571 12 20 12 SR Inc SR Inc
80. 400 341 59 9 9 2 535 2011 4 1 385 685 2011 10 24 JASDAQ 2011 10 23 676 m TDM 621 2011 5 PMDA T
81. 7777 TOP TOP 3 D Matrix Inc 2004 3 D Matrix Inc 2000 4
82. PARTNERSHIP AGREEMENT Excelsior Medical Co Ltd LICENSE AGREEMENT am TDM 711 2011 3 FDA IDE IDE 3 TOP QB 4 og 4 1 11 4 12 4 13 3 10 10 A402 158 1 107 9 491 BU 3 4 5 6 99 5 124 9 1 9 3 398 111 39 95 3 55 5 499 71 7 1 75 1 902 5 2 354 TE EMH ti 11 0 3 5 27 4 5 0 510 310 1 BW 9 PR
83. 2011 Phase 1 2012 4 3 2012 3 9 2012 4 3 3 400 TDM 621 400 498 98 14 26 7 52
84. 583 88 3 529 71 4 11 4 12 4 13 4 14 4 15 4 15B 1 107 2 491 3 45 H O0G 93 51 te 92 7G 4 499 71 1 117 1 2998 2 354 5HB 1 091 3 5 1 510 310 1 085 3 515 5 4 309 5 9 USR TE 2012 6 14 2015 4 2 3 2013 4 1 KOL Ke
85. 7777 be Q8 4 og 4 1 11 4 0 TN 5 4 5BB EFS 14 42 400 4 7B7O 5BBBG 737 EPS gn DPS nn nn nn nn nn BPS 137 22 7 502 137 G4 2 120 1595 25 1 2 5j5B4 5 7 TE 917 EFS 5 5 9 0 7 4 Else EPS 4 5 DPS nn nn nn nn nn BPS 1715 1219 172 0 150 2 312 5 SR 2011 7 1 100 948 2011 8 1 4 3 792 m 2012 9 1 2 9 222 2012 6 445 200
86. pH TDM 621 TDM 621 TDM 621
87. Metabolism Excretion ADME SIRNA 21 23 RNA siRNA RNA RNAi RNA mRNA MTA NN Material Transfer Agreement
88. 151 157 dE2 225 227 5 5 59 6 3 99 6 2 195 158 dE 232 225 5 8 3 51 1 99 4 204 1595 159 dE 232 225 5 1 51 1 1 USRTTF 2013 4 2 2012 12 13 2013 4 2 2 0 458 4 58 452
89. 2n2a 54 1E PCT SR 8 D hdatrix Inc MIT akMENDED hID RESTATED EXCLUSTME PATENT LICENSE AGREEAENT FRST ahMENMDMENT SECOhMD MENDIMEMT THIRD MEINPMENMT TO MERDED fb IIT hi katrix mc MIT MSR 2014
90. ri OE 437 gHG 1 198 1 199 3 055 12 15 2 0 Q 0 31 49 112 0 Q 0 0 0 5 31 49 167 g5 B87 1 157 1 150 2 HH 0 Q 0 2 434 131 13 18 100 7 4 1 400 RO amp 4 4 5 3 4 14 5 RQE GO d W 15 BT 7 7 5 B B SR 2012 12 13 2013 4 2 http goo gl Sgzoh 2013 4 1 2012 11 20
91. PDF http www sharedresearch jp 7777 _ o
92. 70 MIT SR CRO PII II
93. http7 www sharedresearchjp 9 726 Shared 05Wesearch 2012 12728 7777 0 I 2 pe lt LL TDM 64 1 TDM 621 RADA16 TDM 621 TDM 64 1 2012 4 2012 2 c TDM 631 RADA16 TDM 631 TDM 631
94. 621 TDM 621 PMDA TDM 621 1 4538 1 4521 T
95. 0 5 0 0 0 1 49 157 1 1Qg 1 35g 2 070 1 QgG 1 34g 2 0G 1 n5 1 5BG 1 2 11 18 958 5 1 1857 1 150 7 HH 21 22 3 0 0 544 5 B 1 758 MSR 2012 4 3 D Matrix Inc 70 1 2019 4
96. 011 4 TDM 621 57 2011 5 PMDA TDM 621 2012 2012 2012 4 TDM 621 2010 9 17 Daewoong Pharmaceutical Co LTD PARTNERSHIP AGREEMENT Excelsior Medical Co Ltd LICENSE AGREEMENT 5
97. 6 26 Shared 8 esearch 2012 12728 7777 2 3 4 PMDA FDA 8 5 PMDA FDA 6 2 3 7 TDM 621 TDM 711 TDM 641 TDM 631 TDM 621 RADA16
98. 60 10 T 5 6 Millennium Research Group http www sharedresearch jp 15 26 Shared eesearch 2012 12728 7777 OO 5 6 1 800 1 600 ee 1 400 mis Proprietary 0 1 200 Nonproprietary 9 lt 5 B00 2 8 500 400 14 6 zh Millenmium Research Group LS Markel for Dental HIQrmaterlal 2010 ag 9 010 a 1 1 1 013 1 MIT
99. CE FDA CE 2014 4 2014 4 http7Xwww sharedresearchJp 2 26 Shared Wesearch 2012 12728 7777 m TDM 711 2012 2 1 5 FDA m TDM 641 2013 4 i 2015 4 m 1 2013 4 2
100. DM 621 TDM 621 m TDM 711 2011 7 FDA IDE http7Xwww sharedresearchJp 17 26 s Shared Wesearch 2012 12728 7777 2012 4 1 400 TDM 621 400 190
101. SEAD MBA 1996 2006 CSBA 2007 CSBA 2008 JASDAOQ 2008 2012 7 TOP 2012 4 22 19 39 9 2 7 TOP IR 2 4 TOP TDE Investgatonal Device Exemption FDA
102. SG 150 2010 4 400 64 1 2010 4 174 E 50 TDM 621 122 482 2010 4 65 510 60 534 61 8 19 am TDM 621 2010 4 2011 4 PMDA 2010 8 2010 9 Daewoong Pharmaceutical Co LTD
103. y Opinion Leader 2011 11 m 2014 4 m 2015 4 2015 4
Download Pdf Manuals
Related Search